Cargando…

Efficacy of infliximab in the treatment of Kawasaki disease: A systematic review and meta-analysis

The present study aimed to review the relevant studies in order to determine the efficacy of infliximab (IFX) in the treatment of Kawasaki disease (KD). The relevant studies were retrieved using the PubMed, Cochrane and Embase databases. Key sources in the literature were reviewed; all articles publ...

Descripción completa

Detalles Bibliográficos
Autores principales:	Lu, Zhongxing, Wang, Fen, Lv, Haitao
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	D.A. Spandidos 2021
Materias:	Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7678622/ https://www.ncbi.nlm.nih.gov/pubmed/33235624 http://dx.doi.org/10.3892/etm.2020.9447

Ejemplares similares

The effectiveness of infliximab for Kawasaki disease in children: systematic review and meta-analysis
por: Li, Dan, et al.
Publicado: (2021)

Infliximab Treatment for Refractory Kawasaki Disease in Korean Children
por: Song, Min Seob, et al.
Publicado: (2010)

Infliximab, Is It Really a New Horizon for the Treatment of Kawasaki Disease?
por: Eun, Lucy Youngmin
Publicado: (2019)

Infliximab as rescue therapy in refractory Kawasaki disease
por: Rodríguez-González, Moisés, et al.
Publicado: (2014)

Efficacy and safety of adalimumab in comparison to infliximab for Crohn's disease: A systematic review and meta-analysis
por: Yang, Hua-Hua, et al.
Publicado: (2022)

Infliximab Treatment for Intravenous Immunoglobulin-resistant Kawasaki Disease: a Multicenter Study in Korea
por: Hur, Gyu, et al.
Publicado: (2018)

Efficacy and tolerability of infliximab retreatment in patients with inflammatory bowel disease: a systematic review and meta-analysis
por: Yang, Seungwon, et al.
Publicado: (2021)

Infliximab as a rescue therapy in the management of refractory typical infantile Kawasaki disease
por: Venkatnarayanan, K., et al.
Publicado: (2020)

Kawasaki Disease: A Systematic Review and Meta‐Analysis of Benefits and Harms of Common Treatments
por: James, Karen E., et al.
Publicado: (2021)

Infliximab in hidradenitis suppurativa: A systematic review and meta‐analysis
por: Shih, Terri, et al.
Publicado: (2022)

Current knowledge of TNF-α monoclonal antibody infliximab in treating Kawasaki disease: a comprehensive review
por: Chen, Jiaying, et al.
Publicado: (2023)

Comparative efficacy and safety of biosimilar infliximab and other biological treatments in ankylosing spondylitis: systematic literature review and meta-analysis
por: Baji, Petra, et al.
Publicado: (2014)

Infliximab as an alternative therapy for refractory adult onset Kawasaki disease: A case report
por: Kawaguchi, Takeshi, et al.
Publicado: (2018)

Inﬂiximab for intensification of primary therapy for patients with Kawasaki disease and coronary artery aneurysms at diagnosis
por: Miyata, Koichi, et al.
Publicado: (2023)

Comparative efficacy and safety of infliximab and vedolizumab therapy in patients with inflammatory bowel disease: a systematic review and meta-analysis
por: Peyrin-Biroulet, Laurent, et al.
Publicado: (2022)

Analysis on the MRI and BAEP Results of Neonatal Brain With Different Levels of Bilirubin
por: Lu, Zhongxing, et al.
Publicado: (2022)

Corrigendum: Analysis on the MRI and BAEP results of neonatal brain with different levels of bilirubin
por: Lu, Zhongxing, et al.
Publicado: (2022)

Infliximab for the treatment of intravenous immunoglobulin resistant Kawasaki disease complicated by coronary artery aneurysms: a case report
por: Brogan, Robert J, et al.
Publicado: (2009)

A systematic review on the efficacy and safety of Infliximab in patients with psoriasis
por: Wang, Jin, et al.
Publicado: (2015)

Surgical myocardial revascularization outcomes in Kawasaki disease: systematic review and meta-analysis
por: Salsano, Antonio, et al.
Publicado: (2021)

A comparison of efficacy of six prediction models for intravenous immunoglobulin resistance in Kawasaki disease
por: Qian, Weiguo, et al.
Publicado: (2018)

Diagnostic significance of noncoding RNAs in kawasaki disease: A systematic review and meta-analysis
por: Zhong, Xiaoling, et al.
Publicado: (2023)

Intravenous Immunoglobulin Gamma (IVIG) versus IVIG Plus Infliximab in Young Children with Kawasaki Disease
por: Han, Chun-Ling, et al.
Publicado: (2018)

Comparison of infliximab with adalimumab for the treatment of non-infectious uveitis: a systematic review and meta-analysis
por: Liu, Weishai, et al.
Publicado: (2023)

Influence of previous corticosteroid treatment on the efficacy and safety of infliximab therapy in Crohn disease
por: Liu, Ailing, et al.
Publicado: (2019)

Efficacy of Infliximab for the Treatment of Oral Manifestation of Crohn’s Disease
por: Aginbay, Aibar, et al.
Publicado: (2022)

Clinical Features in Children With Kawasaki Disease Shock Syndrome: A Systematic Review and Meta-Analysis
por: Zheng, Zhimin, et al.
Publicado: (2021)

Usefulness of natriuretic peptide for the diagnosis of Kawasaki disease: a systematic review and meta-analysis
por: Lin, Kuan-Ho, et al.
Publicado: (2015)

Monoclonal antibody therapy for Kawasaki disease: a protocol for systematic reviews and meta-analysis
por: Nomura, Osamu, et al.
Publicado: (2016)

Kawasaki Disease and the Use of the Rotavirus Vaccine in Children: A Systematic Review and Meta-Analysis
por: Mellone, Natália Gibim, et al.
Publicado: (2019)

Predictors of intravenous immunoglobulin-resistant Kawasaki disease in children: a meta-analysis of 4442 cases
por: Li, Xuan, et al.
Publicado: (2018)

Corticosteroid therapy for primary treatment of Kawasaki disease – weight of evidence: a meta-analysis and systematic review of the literature
por: Athappan, Ganesh, et al.
Publicado: (2009)

Kawasaki disease associated with Mycoplasma pneumoniae
por: Tang, Yunjia, et al.
Publicado: (2016)

A Meta-Analysis of Efficacy and Safety of Infliximab for Prevention of Postoperative Recurrence in Patients with Crohn's Disease
por: Huang, He, et al.
Publicado: (2018)

Infliximab and biosimilar infliximab in psoriasis: efficacy, loss of efficacy, and adverse events
por: Subedi, Smriti, et al.
Publicado: (2019)

Efficacy of infliximab, cyclosporine and tacrolimus on ulcerative colitis: A meta-analysis
por: Jia, Xuemei, et al.
Publicado: (2020)

Neutropenia Is Not Associated With the Outcomes in Patients With Kawasaki Disease
por: Tang, Yunjia, et al.
Publicado: (2021)

Safety and Efficacy of Infliximab in Severe Alcoholic Hepatitis: A Systematic Review
por: Majeed, Muhammad B, et al.
Publicado: (2019)

Comparing adalimumab and infliximab in the prevention of postoperative recurrence of Crohn’s disease: a systematic review and meta-analysis
por: Gangwani, Manesh Kumar, et al.
Publicado: (2023)

Effect of Early Intravenous Immunoglobulin Therapy in Kawasaki Disease: A Systematic Review and Meta-Analysis
por: Yan, Fan, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_enrc6d02ti4v48gkq9429gi8v4